Lycium barbarum Polysaccharide Inhibited Hypoxia-Inducible Factor 1 in COPD Patients

References

• VestboJ, HurdSS, Rodriguez-RoisinR. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)–why and what? Clin Respir J. 2012;6(4):208–214. doi:10.1111/crj.1200222906068
   PubMed Web of Science ®Google Scholar
• FullertonDG, GordonSB, CalverleyPM. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9706):1964–1965;author reply 1965–1966. doi:10.1016/S0140-6736(09)62116-4
   PubMed Web of Science ®Google Scholar
• BarnesPJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):71–86. doi:10.1016/j.ccm.2013.10.00424507838
   PubMed Web of Science ®Google Scholar
• SemenzaGL. Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol. 2014;76:39–56. doi:10.1146/annurev-physiol-021113-17032223988176
   PubMed Web of Science ®Google Scholar
• ZhaoX, GaoS, RenH, et al. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Cancer Res. 2014;74(9):2455–2464. doi:10.1158/0008-5472.CAN-13-300924599125
   PubMed Web of Science ®Google Scholar
• GuiD, LiY, ChenX, GaoD, YangY, LiX. HIF1 signaling pathway involving iNOS, COX2 and caspase9 mediates the neuroprotection provided by erythropoietin in the retina of chronic ocular hypertension rats. Mol Med Rep. 2015;11(2):1490–1496. doi:10.3892/mmr.2014.285925370745
   PubMed Web of Science ®Google Scholar
• SzkanderaJ, KnechtelG, StotzM, et al. Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis. Anticancer Res. 2010;30(6):2393–2397.20651398
   PubMed Web of Science ®Google Scholar
• YuZG, WangBZ, ChengZZ. The association of genetic polymorphisms of hypoxia inducible factor-1 alpha and vascular endothelial growth factor with increased risk of chronic obstructive pulmonary disease: a case-control study. Kaohsiung J Med Sci. 2017;33(9):433–441. doi:10.1016/j.kjms.2017.05.01428865600
   PubMed Web of Science ®Google Scholar
• FuX, ZhangF. Role of the HIF-1 signaling pathway in chronic obstructive pulmonary disease. Exp Ther Med. 2018;16(6):4553–4561. doi:10.3892/etm.2018.678530542404
   PubMed Web of Science ®Google Scholar
• ChengJ, ZhouZW, ShengHP, et al. An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides. Drug Des Devel Ther. 2015;9:33–78. doi:10.2147/DDDT.S72892
   PubMed Web of Science ®Google Scholar
• DengHB, CuiDP, JiangJM, FengYC, CaiNS, LiDD. Inhibiting effects of Achyranthes bidentata polysaccharide and Lycium barbarum polysaccharide on nonenzyme glycation in D-galactose induced mouse aging model. Biomed Environ Sci. 2003;16(3):267–275.14631832
   PubMed Web of Science ®Google Scholar
• LuoQ, CaiY, YanJ, SunM, CorkeH. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004;76(2):137–149. doi:10.1016/j.lfs.2004.04.05615519360
   PubMed Web of Science ®Google Scholar
• ShiGJ, ZhengJ, WuJ, et al. Protective effects of Lycium barbarum polysaccharide on male sexual dysfunction and fertility impairments by activating hypothalamic pituitary gonadal axis in streptozotocin-induced type-1 diabetic male mice. Endocr J. 2017;64(9):907–922. doi:10.1507/endocrj.EJ16-043028794341
   PubMed Web of Science ®Google Scholar
• KwokSS, BuY, LoAC, et al. A systematic review of potential therapeutic use of Lycium barbarum polysaccharides in disease. Biomed Res Int. 2019;2019:4615745. doi:10.1155/2019/461574530891458
   PubMed Web of Science ®Google Scholar
• LeeJW, KoJ, JuC, EltzschigHK. Hypoxia signaling in human diseases and therapeutic targets. Exp Mol Med. 2019;51(6):68. doi:10.1038/s12276-019-0235-1
   PubMed Web of Science ®Google Scholar
• GanL, Hua ZhangS, Liang YangX, Bi XuH. Immunomodulation and antitumor activity by a polysaccharide-protein complex from Lycium barbarum. Int Immunopharmacol. 2004;4(4):563–569. doi:10.1016/j.intimp.2004.01.02315099534
   PubMed Web of Science ®Google Scholar
• ZhangM, TangX, WangF, ZhangQ, ZhangZ. Characterization of Lycium barbarum polysaccharide and its effect on human hepatoma cells. Int J Biol Macromol. 2013;61:270–275. doi:10.1016/j.ijbiomac.2013.06.03123817098
   PubMed Web of Science ®Google Scholar
• BoR, SunY, ZhouS, et al. Simple nanoliposomes encapsulating Lycium barbarum polysaccharides as adjuvants improve humoral and cellular immunity in mice. Int J Nanomedicine. 2017;12:6289–6301. doi:10.2147/IJN.S13682028894367
   PubMed Web of Science ®Google Scholar
• ZhangXR, QiCH, ChengJP, et al. Lycium barbarum polysaccharide LBPF4-OL may be a new Toll-like receptor 4/MD2-MAPK signaling pathway activator and inducer. Int Immunopharmacol. 2014;19(1):132–141. doi:10.1016/j.intimp.2014.01.01024462389
   PubMed Web of Science ®Google Scholar
• TengP, LiY, ChengW, ZhouL, ShenY, WangY. Neuroprotective effects of Lycium barbarum polysaccharides in lipopolysaccharide-induced BV2 microglial cells. Mol Med Rep. 2013;7(6):1977–1981. doi:10.3892/mmr.2013.144223620217
   PubMed Web of Science ®Google Scholar
• XinYF, WanLL, PengJL, GuoC. Alleviation of the acute doxorubicin-induced cardiotoxicity by Lycium barbarum polysaccharides through the suppression of oxidative stress. Food Chem Toxicol. 2011;49(1):259–264. doi:10.1016/j.fct.2010.10.02821056614
   PubMed Web of Science ®Google Scholar
• CTS. Guidelines of COPD for primary doctors. Chin J Gen Pract. 2018;11(17):856–870.
   Google Scholar
• YasuoM, MizunoS, KraskauskasD, et al. Hypoxia inducible factor-1alpha in human emphysema lung tissue. Eur Respir J. 2011;37(4):775–783. doi:10.1183/09031936.0002291020562128
   PubMed Web of Science ®Google Scholar
• ZhangHX, YangJJ, ZhangSA, et al. HIF-1alpha promotes inflammatory response of chronic obstructive pulmonary disease by activating EGFR/PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 2018;22(18):6077–6084. doi:10.26355/eurrev_201809_1594630280794
   PubMed Web of Science ®Google Scholar
• MoJH, KimJH, LimDJ, KimEH. The role of hypoxia-inducible factor 1alpha in allergic rhinitis. Am J Rhinol Allergy. 2014;28(2):e100–e106. doi:10.2500/ajra.2014.28.402524717944
   PubMed Web of Science ®Google Scholar
• SemenzaGL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3(10):721–732. doi:10.1038/nrc118713130303
   PubMed Web of Science ®Google Scholar
• LiJ, XuY, JiaoH, WangW, MeiZ, ChenG. Sumoylation of hypoxia inducible factor-1alpha and its significance in cancer. Sci China Life Sci. 2014;57(7):657–664. doi:10.1007/s11427-014-4685-324916276
   PubMed Web of Science ®Google Scholar
• Karpel-MasslerG, WesthoffMA, KastRE, et al. Simultaneous Interference with HER1/EGFR and RAC1 signaling drives cytostasis and suppression of survivin in human glioma cells in vitro. Neurochem Res. 2017;42(5):1543–1554. doi:10.1007/s11064-017-2213-028271323
   PubMed Web of Science ®Google Scholar
• YorkER, Varella-GarciaM, BangTJ, AisnerDL, CamidgeDR. Tolerable and effective combination of full-dose crizotinib and osimertinib targeting MET amplification sequentially emerging after T790M positivity in EGFR-mutant non-small cell lung cancer. J Thorac Oncol. 2017;12(7):e85–e88. doi:10.1016/j.jtho.2017.02.02028274743
   PubMedGoogle Scholar
• TosunerZ, BozkurtSU, KilicT, YilmazB. The role of EGFR, hepatocyte growth factor receptor (c-Met), c-ErbB2 (HER2-neu) and clinicopathological parameters in the pathogenesis and prognosis of chordoma. Turk Patoloji Derg. 2017;33(2):112–120. doi:10.5146/tjpath.2016.0137828272674
   PubMedGoogle Scholar
• KiersD, WielockxB, PetersE, et al. Short-term hypoxia dampens inflammation in vivo via enhanced adenosine release and adenosine 2B receptor stimulation. EBioMedicine. 2018;33:144–156. doi:10.1016/j.ebiom.2018.06.02129983349
   PubMed Web of Science ®Google Scholar
• BowserJL, LeeJW, YuanX, EltzschigHK. The hypoxia-adenosine link during inflammation. J Appl Physiol. 2017;123(5):1303–1320. doi:10.1152/japplphysiol.00101.201728798196
   PubMed Web of Science ®Google Scholar
• RiegelAK, FaigleM, ZugS, et al. Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood. 2011;117(8):2548–2555. doi:10.1182/blood-2010-10-31395721173118
   PubMed Web of Science ®Google Scholar
• YuanX, LeeJW, BowserJL, NeudeckerV, SridharS, EltzschigHK. Targeting hypoxia signaling for perioperative organ injury. Anesth Analg. 2018;126(1):308–321. doi:10.1213/ANE.000000000000228828759485
   PubMed Web of Science ®Google Scholar
• HuCJ, WangLY, ChodoshLA, KeithB, SimonMC. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol. 2003;23(24):9361–9374. doi:10.1128/MCB.23.24.9361-9374.200314645546
   PubMed Web of Science ®Google Scholar
• ShengW, FanW. Effect of Lycium barbarum polysaccharide on ability of hypoxia and anti-fatigue in mice. J Xinxiang Med Coll. 2011;28(3):298–300.
   Google Scholar
• LiX, WangB, LiuJ, ZhangS. Study of effect of LBP on antihypoxia in mice. J Huazhong Agricl Univ. 1999;18(3):283–285.
   Google Scholar
• ZhuY, SunY, GuanW, et al. Lycium barbarum polysaccharides enhances SIRT1 expression and decreases MMP-9 and HIF-1a expression in hypoxic pulmonary vascular smooth muscle cells. Chin J Cell Mol Immunol. 2016;7(7):906–940.
   Google Scholar
• ChenW, ChengX, ChenJ, et al. Lycium barbarum polysaccharides prevent memory and neurogenesis impairments in scopolamine-treated rats. PLoS One. 2014;9(2):e88076. doi:10.1371/journal.pone.008807624505383
   PubMed Web of Science ®Google Scholar
• KouL, DuM, ZhangC, et al. Polysaccharide purified from Lycium barbarum protects differentiated PC12 cells against LGlu-induced toxicity via the mitochondria-associated pathway. Mol Med Rep. 2017;16(4):5533–5540. doi:10.3892/mmr.2017.728928849165
   PubMed Web of Science ®Google Scholar
• HoYS, YuMS, LaiCS, SoKF, YuenWH, ChangRC. Characterizing the neuroprotective effects of alkaline extract of Lycium barbarum on beta-amyloid peptide neurotoxicity. Brain Res. 2007;1158:123–134. doi:10.1016/j.brainres.2007.04.07517568570
   PubMed Web of Science ®Google Scholar
• HoYS, YuMS, YikSY, SoKF, YuenWH, ChangRC. Polysaccharides from wolfberry antagonizes glutamate excitotoxicity in rat cortical neurons. Cell Mol Neurobiol. 2009;29(8):1233–1244. doi:10.1007/s10571-009-9419-x19499323
   PubMed Web of Science ®Google Scholar
• ChiuK, ChanHC, YeungSC, et al. Modulation of microglia by wolfberry on the survival of retinal ganglion cells in a rat ocular hypertension model. J Ocul Biol Dis Infor. 2009;2(2):47–56. doi:10.1007/s12177-009-9023-919672466
   PubMedGoogle Scholar
• ZhuC, ZhangS. The antitumor and immunoenhancement activity of Lycium barbarum polysaccharides in hepatoma H-22-bearing mice. Acta Nutr Sin. 2006;28:182–183.
   Google Scholar
• ZhuJ, ZhaoLH, ZhaoXP, ChenZ. Lycium barbarum polysaccharides regulate phenotypic and functional maturation of murine dendritic cells. Cell Biol Int. 2007;31(6):615–619. doi:10.1016/j.cellbi.2006.12.00217289406
   PubMed Web of Science ®Google Scholar
• ShengB, ZhaoX, LiangK. Regulatory effect of Lycium barbarum on immunity in over 60 seniors. Pharmacol Clin Chin Mater Med. 1988;4(2):43–44.
   Google Scholar
• MuB, LiuX, XiongJ, GouA. Acute toxicity and mutagenicity of Lycium barbarum polysaccharides. J Environ Occup Med. 2002;19(2):201–202.
   Google Scholar
• LiW, DaiS, ShaoW. Effect of oral administration of Lycium barbarum on superoxide dismutase, Hb, and LPD in seniors. Chin Traditional Herbal Drugs. 1991;22(6):25–26.
   Google Scholar